WHO ICTRP trial
Phase 2 Study of IPH2102 as Maintenance Treatment in Elderly patients with Acute…
EUCTR2012-001594-93-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-001594-93-FR |
|---|---|
| Public title | Phase 2 Study of IPH2102 as Maintenance Treatment in Elderly patients with Acute Myeloid Leukemia |
| Scientific title | Double-Blind Placebo-Controlled Randomized Phase 2 Study of IPH2102 as Maintenance Treatment in Elderly patients with Acute Myeloid Leukemia (AML) in First Complete Remission |
| Primary sponsor | Innate Pharma |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | Acute Myeloid Leukemia in Elderly patients in First Complete Remission MedDRA version: 15.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified… |
| Interventions | Product Code: IPH2102 Pharmaceutical Form: Solution for infusion INN or Proposed INN: ongoing CAS Number: 10000676414 Current Sponsor code: IPH2102 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration… |
| Registration date | Oct 9, 2012 |
| Target size | 150 |
| Secondary IDs | IPH2102-201 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: